Profile data is unavailable for this security.
About the company
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
- Revenue in USD (TTM)0.00
- Net income in USD-26.25m
- Incorporated2017
- Employees58.00
- LocationBiomx Inc22 Einstein St., Floor 4NESS-ZIONA 7414003IsraelISR
- Phone+972 723942377
- Fax+1 8 002535177
- Websitehttps://www.biomx.com/
More ▼
Mergers & acquisitions
| Acquired company | PHGE:ASQ since announced | Transaction value |
|---|---|---|
| Adaptive Phage Therapeutics Inc | 343.48% | 2.11m |
Data delayed at least 15 minutes, as of Sep 21 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BioVie Inc | 0.00 | -37.18m | 16.88m | 18.00 | -- | 0.8891 | -- | -- | -9.63 | -9.63 | 0.00 | 3.10 | 0.00 | -- | -- | 0.00 | -94.32 | -456.35 | -149.75 | -1,810.88 | -- | -- | -- | -- | -- | -- | 0.2969 | -- | -- | -- | -92.67 | -- | -- | -- |
| Ibio Inc | 50.00k | -17.13m | 16.99m | 26.00 | -- | 0.6749 | -- | 339.77 | -13.10 | -17.09 | 0.0262 | 2.92 | 0.0011 | -- | 0.0065 | 1,923.08 | -36.24 | -28.09 | -67.39 | -32.63 | -- | -- | -34,258.00 | -1,467.30 | -- | -- | 0.3666 | -- | -100.00 | -- | 0.9764 | -- | 42.90 | -- |
| Aprea Therapeutics Inc | 1.28m | -12.93m | 17.00m | 7.00 | -- | 0.665 | -- | 13.33 | -3.03 | -3.03 | 0.2898 | 4.95 | 0.0435 | -- | -- | 182,241.40 | -44.09 | -68.66 | -50.11 | -77.19 | -- | -- | -1,013.41 | -42,112.84 | -- | -- | 0.00 | -- | -- | -- | 87.32 | -- | 90.61 | -- |
| NRX Pharmaceuticals Inc | 0.00 | -24.83m | 17.52m | 2.00 | -- | -- | -- | -- | -1.62 | -1.62 | 0.00 | -1.70 | 0.00 | -- | -- | -- | -197.97 | -120.57 | -- | -168.40 | -- | -- | -- | -- | -- | -189.12 | -- | -- | -- | -- | 24.14 | -- | -- | -- |
| OpGen Inc | 1.96m | -22.39m | 17.55m | 100.00 | -- | -- | -- | 8.93 | -20.01 | -20.01 | 1.66 | -8.65 | 0.1553 | -- | 6.09 | -- | -176.99 | -87.95 | -15,455.17 | -127.65 | 3.15 | 15.42 | -1,139.66 | -794.78 | -- | -20.25 | -- | -- | 31.11 | 3.02 | 12.38 | -- | 40.20 | -- |
| Spruce Biosciences Inc | 9.57m | -43.11m | 18.17m | 22.00 | -- | 0.3071 | -- | 1.90 | -1.05 | -1.05 | 0.2338 | 1.43 | 0.095 | -- | -- | 330,069.00 | -42.79 | -41.24 | -52.43 | -46.49 | -- | -- | -450.38 | -1,774.39 | -- | -117.26 | 0.0412 | -- | -- | -- | -3.77 | -- | -- | -- |
| Biomx Inc | 0.00 | -26.25m | 18.25m | 58.00 | -- | -- | -- | -- | -0.4575 | -0.4575 | 0.00 | 0.3929 | 0.00 | -- | -- | 0.00 | -47.79 | -- | -57.76 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 7.59 | -- | -- | -- |
| Finch Therapeutics Group Inc | 0.00 | -14.17m | 18.31m | 18.00 | -- | 1.29 | -- | -- | -8.82 | -8.82 | 0.00 | 8.86 | 0.00 | -- | -- | -- | -25.20 | -- | -28.80 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -87.57 | -- | 34.80 | -- | -- | -- |
| Lyra Therapeutics Inc | 1.82m | -101.39m | 18.46m | 87.00 | -- | 0.5959 | -- | 10.14 | -1.61 | -1.61 | 0.0294 | 0.4733 | 0.0165 | -- | -- | 20,681.82 | -92.07 | -58.01 | -108.51 | -68.69 | -- | -- | -5,570.88 | -6,235.31 | -- | -- | 0.00 | -- | 14.31 | 4.60 | -13.39 | -- | 95.14 | -- |
| Matinas BioPharma Holdings Inc | 0.00 | -22.91m | 18.51m | 32.00 | -- | 0.969 | -- | -- | -5.10 | -5.10 | 0.00 | 3.81 | 0.00 | -- | -- | 0.00 | -78.48 | -44.62 | -85.80 | -48.25 | -- | -- | -- | -2,344.60 | -- | -- | 0.001 | -- | -65.62 | 55.71 | -9.26 | -- | -16.46 | -- |
| NanoViricides Inc | 0.00 | -9.51m | 18.55m | 7.00 | -- | 1.74 | -- | -- | -0.8115 | -0.8115 | 0.00 | 0.9017 | 0.00 | -- | -- | 0.00 | -63.30 | -43.54 | -65.85 | -46.29 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -5.94 | -- | -8.90 | -- |
| Cocrystal Pharma Inc | 0.00 | -17.93m | 18.72m | 12.00 | -- | 1.08 | -- | -- | -1.76 | -1.76 | 0.00 | 1.71 | 0.00 | -- | -- | 0.00 | -61.98 | -50.94 | -66.88 | -52.77 | -- | -- | -- | -1,501.78 | -- | -- | 0.00 | -- | -- | -- | 53.69 | -- | 33.34 | -- |
| Bullfrog AI Holdings, Inc. | 65.00k | -6.08m | 18.92m | 4.00 | -- | 3.51 | -- | 291.07 | -0.8441 | -0.8441 | 0.009 | 0.6860 | 0.0107 | -- | -- | 16,250.00 | -100.10 | -- | -117.94 | -- | 92.00 | -- | -9,331.34 | -- | -- | -328.51 | 0.0596 | -- | 550.00 | -- | -91.11 | -- | -- | -- |
| Brainstorm Cell Therapeutics Inc | 0.00 | -12.75m | 19.36m | 29.00 | -- | -- | -- | -- | -0.2242 | -0.2242 | 0.00 | -0.0443 | 0.00 | -- | -- | 0.00 | -223.03 | -117.19 | -- | -231.65 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 29.18 | -- | -45.34 | -- |
| Synlogic Inc | 3.17m | -56.16m | 19.65m | 6.00 | -- | 1.23 | -- | 6.20 | -7.24 | -7.24 | 0.3549 | 1.37 | 0.0628 | -- | -- | 528,333.30 | -111.31 | -40.57 | -131.17 | -43.82 | -- | -- | -1,771.74 | -3,245.93 | -- | -- | 0.00 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
Data as of Sep 21 2024. Currency figures normalised to Biomx Inc's reporting currency: US Dollar USD
0.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Barclays Bank (Suisse) SAas of 30 Jun 2024 | 25.00k | 0.14% |
| UBS Securities LLCas of 30 Jun 2024 | 4.88k | 0.03% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 2.28k | 0.01% |
| XTX Markets LLCas of 30 Jun 2024 | 2.08k | 0.01% |
| Raymond James Financial Services Advisors, Inc.as of 30 Jun 2024 | 1.00k | 0.01% |
| PNC Bank, NA (Investment Management)as of 30 Jun 2024 | 400.00 | 0.00% |
| Millennium Management LLCas of 30 Jun 2024 | 0.00 | 0.00% |
| Jump Trading LLCas of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
